Novel antibiotics from Tetraphase and Cempra highlighted at ECCMID
This article was originally published in Scrip
Executive Summary
Clinical trials of novel antibiotics featured heavily in the late-breakers session of this week's European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) meeting in Copenhagen with late-stage clinical data for two new products from Cempra and Tetraphase.